Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the Food and Drug Administration.

Novavax Says Its COVID-19 Shot Is on Track for Full FDA Approval After Delay WASHINGTON (AP) — Novavax's closely watched COVID-19 vaccine is on track for full approval after additional ...

WASHINGTON — Novavax’s closely watched COVID-19 vaccine is on track for full ... vaccine safety. With full FDA approval, Novavax would have permission to keep its shot on the market indefinitely.

Novavax's closely watched COVID-19 vaccine is on track for full approval ... about vaccine safety. With full FDA approval, Novavax would have permission to keep its shot on the market indefinitely.

FILE - A vial of the Phase 3 Novavax coronavirus ... At FDA, full vaccine approval is the gold standard. The agency was on track to sign off on Novavax’s license by its April 1 target date ...